From Molecule to Market,
end-to-end services
Global Partnerships across US, EU & GCC
Focus Area - Spanning diverse therapeutic domains
WHO WE ARE
Driving breakthroughs in formulation science
Fenix Research Labs Private Limited, formerly Incozen Therapeutics, is a dynamic, formulation-focused pharmaceutical R&D company headquartered in Hyderabad, India.
We specialize in developing next-generation drug delivery systems that significantly enhance therapeutic performance, patient compliance, and market differentiation.
Our innovative AI-based product selection approach leverages advanced analytics to identify the most promising drug products and optimise their development pathways, ensuring unparalleled efficiency and success in a highly competitive market.
10+
Formulations delivered
since inception
10
Formulations initiated since rebranding in 2025
WHAT WE DO
Unified capabilities driving faster, smarter development
Our seamless, integrated approach accelerates timelines, reduces risk, and simplifies the entire drug development journey under one roof.
1
Formulation Development
Crafting innovative, patient-centric dosage forms designed for efficacy, compliance, and market success
2
Analytical Development
Ensuring product quality, safety, and global compliance through rigorous analytical science.
3
Pre-Clinical Development
De-risking drug candidates early with critical data to inform smart development decisions.
OUR STRENGTHS
Expertise that powers progress
Our deep expertise across key development pillars ensures every step toward regulatory submission is guided by scientific rigour and precision, helping bring your product to market efficiently and confidently.
Product Development
Advanced development pathways for novel and generic drug products
Impurity Profiling & Nitrosamine Testing
Precise qualification and risk assessment to meet global compliance
Bio-analytical Services
Robust method development for non GLP studies
Pharmacokinetics & Metabolism (ADME)
Comprehensive drug absorption, distribution, metabolism, & excretion studies
BEYOND CAPABILITIES
The Fenix promise
Because drug development demands more than scientific rigour — it requires trust, precision, and a partner who shares your vision.
Integrated Solutions
Flexible & Collaborative Partnerships
Cost-Effectiveness & Speed
Innovation & Patient-Centric Approach
Global Reach
OUR TEAM
Decades of collective expertise
Our multidisciplinary team brings diverse perspectives and deep expertise to every project, propelling your drug candidates forward with confidence.
Mentor in Chief
Dr. Swaroop Vakkalanka
Recognised for his visionary leadership and contributions to innovative cancer therapeutics, Dr. Swaroop Vakkalanka brings over 30 years of leadership in drug discovery and development.
Chief Executive Officer
Dr. Satheesh Thappali
With over 24 years in quality management, operations and drug development, Dr. Thappali leads Fenix’s mission to pioneer smarter therapies,
Chief Scientific Officer
Dr. Sridhar Veeraraghavan
With extensive expertise in analytical sciences, product development, ADME studies, and impurity profiling, Dr. Veeraraghavan consistently upholds the highest standards of scientific rigor and quality